(Q90211923)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31544831%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

title

Human Domain Antibodies to Conserved Epitopes on HER2 Potently Inhibit Growth of HER2-Overexpressing Human Breast Cancer Cells In Vitro (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31544831%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

author name string

Hongqian Wang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31544831%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

Yanping Wang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31544831%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

Zuoxiang Xiao

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31544831%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

Wei Li

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31544831%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

Dimiter S Dimitrov

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31544831%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

Weizao Chen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31544831%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

publication date

18 March 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31544831%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31544831%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31544831%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31544831%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

12 April 2020

copyright license

start time

18 March 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

12 December 2020

Receptors for epidermal growth factor and other polypeptide mitogens

1 reference

12 December 2020

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

12 December 2020

Single domain camel antibodies: current status.

1 reference

12 December 2020

Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth

1 reference

12 December 2020

Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab

1 reference

12 December 2020

Heregulin targets gamma-catenin to the nucleolus by a mechanism dependent on the DF3/MUC1 oncoprotein

1 reference

12 December 2020

Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex

1 reference

12 December 2020

Insulin-like growth factor-I receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells

1 reference

12 December 2020

Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies

1 reference

12 December 2020

The epidermal growth factor receptor family: biology driving targeted therapeutics

1 reference

12 December 2020

Construction of a large phage-displayed human antibody domain library with a scaffold based on a newly identified highly soluble, stable heavy chain variable domain

1 reference

12 December 2020

Monoclonal antibody pharmacokinetics and pharmacodynamics

1 reference

12 December 2020

Human domain antibodies to conserved sterically restricted regions on gp120 as exceptionally potent cross-reactive HIV-1 neutralizers

1 reference

12 December 2020

Construction of a human antibody domain (VH) library

1 reference

12 December 2020

A large human domain antibody library combining heavy and light chain CDR3 diversity

1 reference

12 December 2020

Clinical pharmacokinetics of therapeutic monoclonal antibodies

1 reference

12 December 2020

Pertuzumab in combination with trastuzumab shows significantly enhanced antitumor activity in HER2-positive human gastric cancer xenograft models

1 reference

12 December 2020

Crystal Structure of a Human Single Domain Antibody Dimer Formed through VH-VH Non-Covalent Interactions

1 reference

12 December 2020

Targeting high affinity and epitope-distinct oligoclonal nanobodies to HER2 over-expressing tumor cells

1 reference

12 December 2020

Trastuzumab: updated mechanisms of action and resistance in breast cancer

1 reference

12 December 2020

HER2-positive gastric cancer

1 reference

12 December 2020

Her2 activation mechanism reflects evolutionary preservation of asymmetric ectodomain dimers in the human EGFR family

1 reference

12 December 2020

Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic Implications

1 reference

12 December 2020

Targeting Three Distinct HER2 Domains with a Recombinant Antibody Mixture Overcomes Trastuzumab Resistance

1 reference

12 December 2020

HER2 driven non-small cell lung cancer (NSCLC): potential therapeutic approaches

1 reference

12 December 2020

A Single Domain-Based Anti-Her2 Antibody Has Potent Antitumor Activities.

1 reference

12 December 2020

Intratumor lactate levels reflect HER2 addiction status in HER2-positive breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.3390/ANTIB8010025

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31544831%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31544831%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

1 reference